← Back to Clinical Trials
Recruiting NCT07065292

NCT07065292 Plantar Sensation, Position Sense, and Weight-Bearing Asymmetry Related to Balance and Mobility Post-Stroke

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07065292
Status Recruiting
Phase
Sponsor Afyonkarahisar Health Sciences University
Condition Chronic Stroke
Study Type OBSERVATIONAL
Enrollment 22 participants
Start Date 2025-05-20
Primary Completion 2026-01-20

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 22 participants in total. It began in 2025-05-20 with a primary completion date of 2026-01-20.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to examine how sensory deficits and weight-bearing asymmetry affect posture, balance, and mobility in individuals with chronic stroke. The research focuses on evaluating the relationships between plantar foot sensation, lower extremity position sense, and asymmetrical weight distribution with functional abilities such as walking and postural control. Participants will undergo non-invasive assessments, including sensation tests, mobility and balance evaluations, and postural measurements. A total of 24 individuals with chronic stroke who are receiving physiotherapy at a rehabilitation center in Konya, Türkiye, will be included. The results of this observational, cross-sectional study may contribute to a better understanding of the sensory-motor interactions in stroke survivors and support the development of more targeted rehabilitation strategies.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of stroke confirmed by a physician (via official report) * Minimum of 6 months since stroke onset * Aged 18 years or older * Mini-Mental State Examination score ≥ 20 * Brunnstrom lower extremity stage ≥ 3 * Ability to complete assessments with or without walking aids * Voluntary participation Exclusion Criteria: * Additional neurological, metabolic, or orthopedic conditions * Severe vision or hearing impairments * Modified Ashworth Score of 4 in any lower limb muscle

Contact & Investigator

Central Contact

Uğurcan Turkoz Physiotherapist

✉ turkozugurcan@gmail.com

📞 +90 554 448 17 77

Principal Investigator

Yunus Emre Kundakcı Assoc. Prof.

PRINCIPAL INVESTIGATOR

Afyonkarahisar Health Sciences University

Frequently Asked Questions

Who can join the NCT07065292 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07065292 currently recruiting?

Yes, NCT07065292 is actively recruiting participants. Contact the research team at turkozugurcan@gmail.com for enrollment information.

Where is the NCT07065292 trial being conducted?

This trial is being conducted at Afyonkarahisar, Turkey (Türkiye).

Who is sponsoring the NCT07065292 clinical trial?

NCT07065292 is sponsored by Afyonkarahisar Health Sciences University. The principal investigator is Yunus Emre Kundakcı Assoc. Prof. at Afyonkarahisar Health Sciences University. The trial plans to enroll 22 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology